|Dr Andrew Boyd|
M.B.B.S. (Melb.), F.R.A.C.P.
Professor of Experimental Haematology, University of Queensland Clinical Haematologist and Medical Oncologist
Dr Andrew Boyd has practised for 25 years as a clinical haematologist with particular interests in haematological oncology and autoimmune disorders (ITP, SLE, AIHA).
He graduated from University of Melbourne and trained in haematology at the Royal Melbourne and Austin Hospitals. During advanced training he completed a PhD in tumour immunology and then carried out post doctoral research on leukaemia before moving to the Dana Farber Cancer Institute in Boston to work on the lymphoma and acute and chronic leukaemias of lymphoid origin.
He returned to Australia in 1985 to establish a research lab at the Walter and Eliza Institute and to take up an appointment as a consultant in the Medical Oncology Department of the Royal Melbourne Hospital. In the late 80s he established one of the first Diagnostic Flow Cytometry labs in Australia within the Haematology Department at the Royal Melbourne Hospital with a particular emphasis on the application of this method to diagnosis of haematological malignancies.
In 1996 he moved to Brisbane to take up the Chair of Experimental Haematology at the University of Queensland. In the same year he was appointed as a consultant in clinical haematology at Royal Brisbane Hospital and is registered in both Clinical Haematology and Oncology. His research laboratory is based at the Queensland Institute of Medical Research and carries out both basic and applied cancer research with an emphasis on leukaemia and lymphoma.